This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
5hm1
From Proteopedia
(Difference between revisions)
m (Protected "5hm1" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
| - | The entry 5hm1 is ON HOLD | + | The entry 5hm1 is ON HOLD until Paper Publication |
| - | Authors: | + | Authors: Hock, M., Caillat, C., Haffke, M., Weissenhorn, W. |
Description: Superpotent bi-specific llama VHH antibodies neutralize HIV via gp41 and gp120 epitopes. Epitope characterization on G120 and gp41 used to design bi-specific superpotent broadly HIV neutralizing VHH | Description: Superpotent bi-specific llama VHH antibodies neutralize HIV via gp41 and gp120 epitopes. Epitope characterization on G120 and gp41 used to design bi-specific superpotent broadly HIV neutralizing VHH | ||
[[Category: Unreleased Structures]] | [[Category: Unreleased Structures]] | ||
| - | [[Category: Verrips, T]] | ||
| - | [[Category: Kwong, P]] | ||
[[Category: Weissenhorn, W]] | [[Category: Weissenhorn, W]] | ||
[[Category: Haffke, M]] | [[Category: Haffke, M]] | ||
| - | [[Category: Back, J.W]] | ||
| - | [[Category: Weiss, R.A]] | ||
| - | [[Category: Strokappe, N.M]] | ||
| - | [[Category: Rutten, L]] | ||
| - | [[Category: Chen, L]] | ||
[[Category: Hock, M]] | [[Category: Hock, M]] | ||
[[Category: Caillat, C]] | [[Category: Caillat, C]] | ||
| - | [[Category: Mccoy, L.E]] | ||
Revision as of 21:53, 12 July 2016
Unreleased structure
The entry 5hm1 is ON HOLD until Paper Publication
Authors: Hock, M., Caillat, C., Haffke, M., Weissenhorn, W.
Description: Superpotent bi-specific llama VHH antibodies neutralize HIV via gp41 and gp120 epitopes. Epitope characterization on G120 and gp41 used to design bi-specific superpotent broadly HIV neutralizing VHH
